Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses

被引:8
|
作者
Campione, Elena [1 ]
Rivieccio, Antonia [1 ]
Shumak, Ruslana Gaeta [1 ]
Costanza, Gaetana [2 ]
Cosio, Terenzio [1 ,2 ]
Lambiase, Sara [1 ]
Garofalo, Virginia [1 ]
Artosi, Fabio [1 ]
Lozzi, Flavia [1 ]
Freni, Claudia [3 ]
Romeo, Alice [3 ]
Dika, Emi [4 ]
Falconi, Mattia [3 ]
Bianchi, Luca [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Syst Med, Dermatol Unit, I-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Expt Med, I-00133 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00133 Rome, Italy
[4] Univ Bologna, Oncol Dermatol Unit, IRCCS Azienda Osped Univ Bologna, DIMEC, I-40126 Bologna, Italy
关键词
tirbanibulin; actinic keratosis; field of cancerization; SQUAMOUS-CELL CARCINOMA; PIROXICAM; 0.8-PERCENT; IMMUNE-RESPONSE; SKIN; GUIDELINES; MANAGEMENT; INSIGHTS; CARE;
D O I
10.3390/ph16121686
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Actinic keratosis is a common precancerous skin lesion that can progress into invasive squamous cell carcinomas. Many topical treatments for actinic keratoses often have poor tolerability and prolonged duration. Tirbanibulin is a novel synthetic drug with potent antitumor and antiproliferative activities. Methods: We conducted a single-center, prospective and observational study using tirbanibulin ointment on a 25 cm2 area for 5 consecutive days on 30 participants with AKs on the face or scalp. They were followed for at least 57 days to assess the safety profile and efficacy of the drug as well as treatment satisfaction. We evaluated six signs of local skin reaction (LSR): erythema, scaling, crusting, swelling, blisters/pustules, and erosions/ulcerations, grading the severity as mild, moderate, or severe. The effectiveness was evaluated both clinically and dermoscopically. The treatment satisfaction was assessed using the Treatment Satisfaction Questionnaire for Medication (TSQM 1.4). Results: On day 57, 70% of the patients showed a complete clinical and dermoscopic response. The highest scores obtained from the TSQM 1.4 were more evident in the convenience and side effects domains. Most LSRs, including erythema (83.3%), scaling (30%), and swelling (3.3%), occurred on day 8 but resolved spontaneously. Conclusion: Tirbanibulin is a viable therapeutic option with a short regimen treatment and good tolerability, which favors therapy adherence.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Safety and Tolerability of a single 5-day Treatment Cycle of Tirbanibulin Ointment 1% in Large Field (100cm2): A phase I Trial in patients with Actinic Keratosis
    DuBois, Janet
    Jones, Terry M.
    Lee, Mark S.
    Tomondy, Paul
    Falques, Meritxell
    Kiyasova, Vera
    Jimenez, Gemma
    Padulles, Laura
    Otero, Raquel
    Aubets, Jordi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB220 - AB220
  • [32] An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses
    Rivers, JK
    McLean, DI
    ARCHIVES OF DERMATOLOGY, 1997, 133 (10) : 1239 - 1242
  • [33] Efficacy and safety of 35% Trichloroacetic acid vs Fraxel 1927 nm fractionated laser in the treatment of facial actinic keratoses
    Freeman, A. M.
    Freeman, M. G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 25 - 25
  • [34] Results of a systematic Review and Meta-analysis on the Efficacy and Safety of laser-assisted photodynamic Therapy in the Treatment of actinic Keratoses
    Steeb, T.
    Schlager, J. G.
    Kohl, C.
    Heppt, M.
    Berking, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 72 - 72
  • [35] Safety and efficacy of actinic keratoses reduction with a 3 day application of ingenol disoxate field treatment to the face, chest and balding scalp
    Siegel, Daniel M.
    Tyring, Stephen
    Nahm, Walter K.
    Osterdal, Marie Louise
    Petersen, Astrid H.
    Berman, Brian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB223 - AB223
  • [36] Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients
    Nazzaro, Gianluca
    Carugno, Andrea
    Bortoluzzi, Paolo
    Buffon, Stefano
    Astrua, Chiara
    Zappia, Elena
    Trovato, Emanuele
    Caccavale, Stefano
    Pellegrino, Vincenzo
    Paolino, Giovanni
    Balestri, Riccardo
    Lacava, Rossella
    Ciccarese, Giulia
    Verdelli, Alice
    Barruscotti, Stefania
    Valenti, Mario
    Toni, Giulia
    Giacalone, Serena
    Zavattaro, Elisa
    Gironi, Laura C.
    Mercuri, Santo R.
    Ribero, Simone
    Gisondi, Paolo
    Sena, Paolo
    Marzano, Angelo V.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (11) : 1566 - 1574
  • [37] Preliminary evidence on safety and clinical efficacy of luteolin for patients with prostate cancer
    Naiki, Aya
    Naiki, Taku
    Murakami, Akihiro
    Kato, Hiroyuki
    Takahashi, Satoru
    CANCER SCIENCE, 2025, 116 : 1368 - 1368
  • [38] Efficacy of Photodynamic Therapy vs Other Interventions in Randomized Clinical Trials for the Treatment of Actinic Keratoses A Systematic Review and Meta-analysis
    Patel, Gayatri
    Armstrong, April W.
    Eisen, Daniel B.
    JAMA DERMATOLOGY, 2014, 150 (12) : 1281 - 1288
  • [39] Efficacy of oral Polypodium leucotomos, colchicine cream and ingenol mebutate in the treatment of actinic keratoses and cutaneous field cancerization: a randomized clinical trial
    Miola, Anna Carolina
    Miot, Helio Amante
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (02) : 232 - 236
  • [40] Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses
    Witheiler, DD
    Lawrence, N
    Cox, SE
    Cruz, C
    Cockerell, CJ
    Freemen, RG
    DERMATOLOGIC SURGERY, 1997, 23 (03) : 191 - 196